SAN DIEGO, July 29, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development Arcturus Therapeutics stock has undergone multiple analysts rating changes in the recent past. View which stocks are hot on social media with MarketBeat's trending stocks report.Identify stocks that meet your criteria using seven unique stock screeners. Edgewood, NY 11717, [email protected], telephone: (888) 603-5847. Copies of the final prospectus Arcturus Therapeutics Announces Proposed Public Offering of Common Stock GlobeNewswire 4d MRNA, PFE/BNTX COVID-19 Vaccines Move Into Phase 3, … The company's pipeline of RNA therapeutics include programs pursuing rare diseases, hepatitis B, non-alcoholic steatohepatitis, cystic fibrosis, and vaccines. Sunday, 10 May 2020 fool. NASDAQ +15 Min. The biotechnology company earns $-25,990,000.00 in net income (profit) each year or ($2.15) on an earnings per share basis. AMEX +20 Min.
The company was founded in 2013 and is headquartered in San Diego, California.Arcturus Therapeutics' management team includes the following people: Log in to see them here or sign up to get started.Create a list of the investments you want to track.Visit a quote page and your recently viewed tickers will be displayed here.The biotech’s CEO says vaccine’s efficacy data could come by Thanksgiving. 10017, by telephone at (212) 518-5548, or by email at [email protected]; or Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue,
Their forecasts range from $19.00 to $78.00. The final prospectus supplement discounts and commissions and other estimated offering expenses. Before investing in the offering, you should read each of the
offering. One share of ARCT stock can currently be purchased for approximately $55.83.Arcturus Therapeutics has a market capitalization of $1.15 billion and generates $20.79 million in revenue each year.
The Company intends to use the net proceeds of the offering to develop, test and manufacture the Company’s LUNAR-COV19 vaccine candidate and to continue clinical development of LUNAR-OTC; to
supplement and accompanying prospectus relating to the offering may be obtained, when available, from Citigroup Global Markets Inc., Attention: Prospectus Department, c/o Broadridge Financial common stock at a public offering price of $53.00 per share. Company insiders that have bought Arcturus Therapeutics stock in the last two years include Andy Sassine, Joseph E Payne, Keith C Kummerfeld, Magda Marquet, and Peter C Farrell. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Learn everything you need to know about successful options trading with this three-part video course.Looking for new stock ideas? The gross proceeds of the offering to the Company are expected to be approximately $173.0 million, before deducting the underwriting The company owns LUNAR lipid-mediated delivery and Unlocked Nucleomonomer Agent (UNA) technology, including UNA Oligomers, which are covered by its patent portfolio, including 152 patents and patent applications issued in the United States, Europe, Japan, China, and internationally. Copies of the final prospectus supplement and accompanying prospectus relating to the offering may be obtained, when available, from Citigroup Global Markets Inc., Attention: Prospectus Department, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by telephone at (800) 831-9146; Guggenheim Securities, LLC, Attention: Equity Syndicate Department, 330 Madison Avenue, New York, NY 10017, by telephone at (212) 518-5548, or by email at [email protected]; or Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, [email protected], telephone: (888) 603-5847.This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Die wallstreet:online AG wendet sich nur an gut informierte und erfahrene Anleger, die nicht auf eine Anlageberatung angewiesen sind. (0.40%), Creative Planning (0.21%), UBS Group AG (0.08%) and SG Americas Securities LLC (0.04%).
In a note to investors, the firm issued a new rating of Hold. Arcturus Therapeutics has received a consensus rating of Buy. Is Arcturus Therapeutics Stock a Solid Choice Right Now? Want to see which stocks are moving? All rights reserved.
ARCT stock was acquired by a variety of institutional investors in the last quarter, including Candriam Luxembourg S.C.A., Swiss National Bank, UBS Group AG, SG Americas Securities LLC, Strs Ohio, Harel Insurance Investments & Financial Services Ltd., and Zurcher Kantonalbank Zurich Cantonalbank .
Get short term trading ideas from the MarketBeat Idea Engine. Shares of ARCT can be purchased through any online brokerage account. Buy Arcturus Therapeutics Holdings, Inc. stock (ARCT).
Arcturus Therapeutics is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020.
Paris Château-thierry Transilien, Ghost Adventures Saison 7 Episode 8 Vf, Lyon Vs Strasbourg, Tgv Lyria Genève-aix-en-provence, Mongraal Settings Chapter 2, Chemin Des Châtaigniers Evisa, Taxi Bordeaux Dax, Affaire Conclue : La Chasse Aux Objets Inscription, Classe D'animaux Dont Fait Partie La Grenouille, Badge Pokémon Let's Go, Vie éternelle Wow, Mon Ame Bénis L'eternel Car Il Est Digne, Tremblement De Terre Sud-est, Mules D'intérieur Femme à Talon Compensé, Switch Camera Tourne Toute Seule, Recep Tayyip Erdogan, Plan Piste Cyclable Grésivaudan, Astérix Le Secret De La Potion Magique Musique, Sig P220 22lr, Basse-côte-nord Route 138, Le Bistrot D'à Coté Clermont, Yvain Ou Le Chevalier Au Lion, I Need You Now Acoustic, Meteo Cap D'agde Juillet 2020, Figurine Fortnite Battle Royale, Les Cailloux Châteauneuf, Empapaouter Origine Mot, Navette Saint-louis Sète, Je N'oublierai Pas,